147 related articles for article (PubMed ID: 14500243)
1. CT of posttransplantation lymphoproliferative disorder in pediatric recipients of lung allograft.
Siegel MJ; Lee EY; Sweet SC; Hildebolt C
AJR Am J Roentgenol; 2003 Oct; 181(4):1125-31. PubMed ID: 14500243
[TBL] [Abstract][Full Text] [Related]
2. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients.
Lim GY; Newman B; Kurland G; Webber SA
Radiology; 2002 Mar; 222(3):699-708. PubMed ID: 11867788
[TBL] [Abstract][Full Text] [Related]
3. Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients.
Pickhardt PJ; Siegel MJ; Anderson DC; Hayashi R; DeBaun MR
AJR Am J Roentgenol; 1998 Aug; 171(2):375-82. PubMed ID: 9694455
[TBL] [Abstract][Full Text] [Related]
4. Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease.
Wilde GE; Moore DJ; Bellah RD
AJR Am J Roentgenol; 2005 Nov; 185(5):1335-41. PubMed ID: 16247159
[TBL] [Abstract][Full Text] [Related]
5. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients.
Pickhardt PJ; Siegel MJ
Radiology; 1999 Oct; 213(1):73-8. PubMed ID: 10540643
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative disorders after lung transplantation: imaging features.
Rappaport DC; Chamberlain DW; Shepherd FA; Hutcheon MA
Radiology; 1998 Feb; 206(2):519-24. PubMed ID: 9457207
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr-virus-associated lymphoproliferative disease of the lung: CT and histologic findings.
Collins J; Müller NL; Leung AN; McGuinness G; Mergo PJ; Flint JD; Warner TF; Poirier C; Theodore J; Zander D; Yee HT
Radiology; 1998 Sep; 208(3):749-59. PubMed ID: 9722856
[TBL] [Abstract][Full Text] [Related]
8. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
Muchtar E; Kramer MR; Vidal L; Ram R; Gurion R; Rosenblat Y; Bakal I; Shpilberg O
Transplantation; 2013 Oct; 96(7):657-63. PubMed ID: 23823652
[TBL] [Abstract][Full Text] [Related]
9. Posttransplantation lymphoproliferative disorder in children: manifestations in hematopoietic cell recipients in comparison with liver recipients.
Jeon TY; Kim JH; Eo H; Yoo SY; Yoo KH; Lee SK; Lim GY; Cheon JE
Radiology; 2010 Nov; 257(2):490-7. PubMed ID: 20829531
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disorders: CT findings in immunocompromised children.
Donnelly LF; Frush DP; Marshall KW; White KS
AJR Am J Roentgenol; 1998 Sep; 171(3):725-31. PubMed ID: 9725305
[TBL] [Abstract][Full Text] [Related]
11. Imaging features of posttransplantation lymphoproliferative disorder in pancreas transplant recipients.
Meador TL; Krebs TL; Cheong JJ; Daly B; Keay S; Bartlett S
AJR Am J Roentgenol; 2000 Jan; 174(1):121-4. PubMed ID: 10628466
[TBL] [Abstract][Full Text] [Related]
12. Posttransplant lymphoproliferative disorder: intrathoracic manifestations.
Dodd GD; Ledesma-Medina J; Baron RL; Fuhrman CR
Radiology; 1992 Jul; 184(1):65-9. PubMed ID: 1609104
[TBL] [Abstract][Full Text] [Related]
13. Malignancies incidentally detected at lung transplantation: radiologic and pathologic features.
Strollo DC; Dacic S; Ocak I; Pilewski J; Bermudez C; Crespo MM
AJR Am J Roentgenol; 2013 Jul; 201(1):108-16. PubMed ID: 23789663
[TBL] [Abstract][Full Text] [Related]
14. Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings.
Carignan S; Staples CA; Müller NL
Radiology; 1995 Oct; 197(1):53-8. PubMed ID: 7568853
[TBL] [Abstract][Full Text] [Related]
15. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients.
Marom EM; McAdams HP; Butnor KJ; Coleman RE
J Thorac Imaging; 2004 Apr; 19(2):74-8. PubMed ID: 15071322
[TBL] [Abstract][Full Text] [Related]
17. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
[TBL] [Abstract][Full Text] [Related]
18. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
[TBL] [Abstract][Full Text] [Related]
19. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
20. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
Raj R; Frost AE
J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
